Peptide-Imprinted Conductive Polymer for Low-LOD α-Synuclein Sensing
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for diagnosing Parkinson's disease through α-synuclein concentration measurement in cerebrospinal fluid are limited by high costs, time consumption, and inaccurate detection due to the limit of detection (LOD), and existing molecular imprinting technologies face challenges with protein templates, particularly with protein molecular weight and spatial effects hindering sensitivity and selectivity.
Innovation Solution
A peptide-imprinted conductive polymer is developed using epitope imprinting and electrochemical polymerization, combining conductive polymer monomers, α-synuclein peptide fragments as templates, and 2D materials to create an electrochemical biosensor that measures α-synuclein concentration accurately and efficiently.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If protein templates are used in molecular imprinting, then the polymer can recognize the whole protein, but the high molecular weight and spatial effects hinder the formation of selective imprinted cavities, reducing sensitivity and selectivity
Solution Approach 1:
The patent divides the protein template into smaller peptide fragments (6-22 amino acids) that retain the essential recognition features. This segmentation allows the imprinted cavities to form properly while still recognizing the full protein, resolving the contradiction between sensitivity and template complexity.
Solution Approach 2:
The patent extracts only the necessary peptide fragment from the full protein template for imprinting. By taking out just the essential recognizing elements rather than using the entire protein, the method achieves high sensitivity without the hindrances of full protein templates.
2Measurement precision
If conventional methods (antibodies or biochips) are used to measure α-synuclein, then the detection can be performed, but the methods are costly and time consuming
Solution Approach 1:
The patent replaces conventional biochemical methods (antibody-based or biochip-based) with an electrochemical sensing method. This substitution eliminates the need for complex incubation and detection procedures, achieving rapid measurement without sacrificing accuracy.
Solution Approach 2:
The patent changes the detection parameter from biochemical binding signals to electrochemical signals. This parameter change enables faster measurement and simplifies the overall process while maintaining detection accuracy for α-synuclein.
3Measurement precision
If conventional methods are used, then the detection can be performed, but the limit of detection (LOD) is high, leading to inaccurate detection at early stages
Solution Approach 1:
The patent changes the detection parameter to electrochemical signals, which enable detection at much lower concentrations. This parameter change reduces the limit of detection from conventional methods to the attomole range, allowing accurate detection at early disease stages.
Solution Approach 2:
The patent uses a composite material system combining conductive polymer with peptide imprinting and electrochemical detection. This composite approach enhances the sensitivity and lowers the detection limit compared to conventional single-method approaches.
4Measurement precision
If peptide fragments are used instead of full proteins in imprinting, then the imprinted cavities can form with better selectivity, but the peptide length must be optimized to maintain sensitivity
Solution Approach 1:
The patent optimizes the peptide fragment length parameter to 6-22 amino acids. This specific parameter range achieves the right balance between forming selective imprinted cavities and maintaining sensitivity, resolving the contradiction between selectivity and optimization complexity.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The biosensor provides high sensitivity, low limit of detection, wide current range, good stability, and cost-effectiveness, enabling quick and specific diagnosis of Parkinson's disease.
Implementation Method 1
combining epitope imprinting and electrochemical polymerization
Implementation Method 2
molecular imprinting polymers (MIPs) have been in rapid development in recent years for creating new sensing materials
Implementation Method 3
The peptide-imprinted conductive polymer comprises conductive polymer monomer(s), 2D material(s), and a small peptide fragment
Data Source
AI summary
A peptide-imprinted conductive polymer and use thereof is provided, especially a peptide-imprinted conductive polymer including conductive polymer monomer(s), two-dimensional (2D) material(s), and a small peptide fragment of α-synuclein as template. The peptide-imprinted conductive polymer has high sensibility, detects α-synuclein at low concentrations, thus allowing early diagnosis and treatment of Parkinson's disease.